# Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/retrospective-cost-analysis-of-gemcitabine-in-combination-with-cisplatin-in-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joan H. Schiller,Dominic Tilden,M Aristides,Michael Lees,Adrian Kielhorn,Nikos Maniadakis,Shkun Bhalla |
| Citations | 45 |
| DOI | 10.1016/j.lungcan.2003.06.003 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2029895102 |
| PMID | 14698544 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Adrian Kielhorn](https://scholariq.org/researchers/adrian-kielhorn/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.